Related Experiment Video

Updated: May 24, 2026

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

Influenza vaccination rates in children: a multicenter nationwide study

Hacer Yakın1, Kübra Aykaç1, Sultan İçöz2

  • 1Department of Pediatric Infectious Diseases, Faculty of Medicine, Hacettepe University, Ankara, Türkiye.

The Turkish Journal of Pediatrics
|May 22, 2026
PubMed

Insights

Influenza vaccination rates in children remain low at 4.4%, with lack of awareness and missed check-ups being key barriers. Improving parental education and access can increase pediatric influenza vaccine uptake.

Area of Science:

  • Pediatric Infectious Diseases
  • Public Health
  • Vaccinology

Background:

  • Influenza poses a significant global health threat to children, causing substantial morbidity and mortality.
  • Despite risks, influenza vaccination coverage in pediatric populations remains suboptimal in many regions.
  • Understanding parental factors is crucial for enhancing vaccine uptake and protecting children.

Purpose of the Study:

  • To investigate parental awareness, attitudes, and determinants influencing influenza vaccine uptake in children.
  • To identify key factors associated with low vaccination rates among pediatric populations.
  • To inform strategies for improving influenza vaccination coverage in vulnerable children.

Main Methods:

  • A cross-sectional study involving 5002 families across 38 hospitals in Türkiye.
  • Data collected via face-to-face interviews, with 4404 valid responses analyzed.
  • Statistical analysis, including logistic regression, to identify predictors of vaccination.

Main Results:

  • Overall pediatric influenza vaccination rate was low at 4.4%.
  • Vaccination rates were higher in high-risk children (5.2%) versus non-high-risk (3.5%).
  • Positive associations with uptake included child's chronic illness, higher parental education, and parental vaccination history. Key barriers to non-vaccination were poor check-up attendance and lack of awareness.

Conclusions:

  • Pediatric influenza vaccination coverage is critically low, highlighting a significant public health gap.
  • Lack of awareness, missed routine check-ups, and limited access to private vaccination are major barriers.
  • Targeted interventions addressing parental awareness and healthcare access are needed to improve pediatric influenza immunization rates.
Abstract

Keywords:
childreninfluenzavaccination

More Related Videos

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B05:38

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B

Published on: January 30, 2017

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...